Close
CDMO Safety Testing 2026
Novotech

Anaqua Delivers Enhanced IP Management to Bausch Health

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.
- Advertisement -

Anaqua , the leading innovation and intellectual property management technology provider, announced that Bausch Health Companies Inc. has selected Anaqua’s AQX platform to deliver enhanced IP management across the health care products company’s global operations.

Bausch Health will be using Anaqua’s AQX as their primary IP management system – both for patent and trademark management – replacing their previous IP services provider. Bausch Health will take advantage of Anaqua’s broad range of IP offerings including AcclaimIP for patent analytics, Anaqua Services for patent annuities and trademark renewals, as well as AQX modules for IP contract and financial management.

Commented Bob Romeo, CEO of Anaqua: “Bausch Health is an innovative health care company delivering on its commitment to help people around the world. We are proud to be working with them and to better serve their valuable IP assets through Anaqua’s enhanced innovation and IP management solutions.”

About Anaqua
Anaqua, Inc. is a premium provider of integrated intellectual property (IP) management technology solutions and services. Anaqua’s AQX platform combines best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.

Digital Supply Networks Strengthening Pharma Delivery

The transition from traditional linear supply chains to integrated digital supply networks is revolutionizing how pharmaceutical products are delivered. By leveraging connected visibility and real-time analytics, these networks enhance the resilience of cold chain operations. This technological evolution ensures that healthcare systems can respond dynamically to shifts in demand while maintaining the highest standards of safety and efficiency for patient care.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »